Skip to main content
TipRanks
Go Ultimate75% OFF

Ilika plc (ILIKF) AI Stock Analysis

97 Followers
ILIKF

Ilika plc

(Other OTC:ILIKF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Protected technology and differentiated performanceThe 88-patent portfolio and reported performance benefits provide a defensible technology base for licensing and commercialization. Faster charging, lower vehicle weight and improved safety could strengthen customer adoption if validation continues across automotive and industrial applications.
Negative Factors
Persistent losses and negative marginsPersistent negative gross profit and operating losses show that current commercial activity has not yet produced a scalable, profitable business model. Until pricing, production economics or revenue scale improve, growth may continue to require external funding rather than internally generated earnings.

Ilika plc (ILIKF) vs. SPDR S&P 500 ETF (SPY)

-60%-50%-40%-30%-20%-10%0%10%20%ILIKF-53.80%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$38.78M
Dividend Yield
―
Average Volume (3M)
46.96K
Price to Earnings (P/E)
-4.8
Beta (1Y)
0.96
Revenue Growth
59.48%
EPS Growth
-19.96%
Country
US
Employees
68
Sector
Industrials
Sector Strength
63
Industry
Electrical Equipment & Parts

Ilika plc Business Overview & Revenue Model

Company Description

Ilika plc, an enterprise established in 2004 with its headquarters in Romsey, United Kingdom, focuses on the conception, refinement, and commercial production of solid-state battery technology. These advanced power cells are distributed globally unde...

Ilika plc Earnings Call Summary

Earnings Call Date:Jul 29, 2026(Q4-2026)|% Change Since:-30.14%|Next Earnings Date:Jan 28, 2027
Earnings Call SentimentNeutral

The call presented meaningful technical and commercial progress: first Stereax revenues, manufacturing partnerships (Cirtec), automated pilot line, positive prototype feedback from OEMs, defense and Brompton collaborations, and continued grant support. However, financials remain an important constraint — revenue is still modest, EBITDA losses widened (~19% year‑on‑year), loss per share increased (~14.9%), and pilot capacity and resource limitations constrain immediate scale‑up. There is clear momentum on the technology and validation front but material execution, funding and timing risks remain.

Positive Updates

Revenue Commencement from Stereax and Stable FY Revenue
Reported revenue was GBP 1.1m for FY2026, broadly flat year‑on‑year (0% change). For the first time Ilika recognized commercial revenue from Stereax wafer/electrode sales (GBP 100k), marking the transition from R&D to revenue-generating activity (approximately 9.1% of reported revenue). Management expects this to build through the current financial year.

Negative Updates

Revenue Still Very Modest and Concentrated
Although revenue was stable at GBP 1.1m, commercial revenues are still small: Stereax electrode sales were only GBP 100k in the year (≈9.1% of revenue) and the business remains early stage in commercial traction versus expectations for scale.

Company Guidance

Management guided that Ilika is transitioning to revenue generation across two product lines (Goliath large‑format and Stereax miniature) and gave detailed metrics: FY2026 revenue was £1.1m (flat YoY) including £0.1m of electrode sales to Cirtec, grant income ~£1.0m, EBITDA loss £6.2m (vs £5.2m prior) and loss per share 4.02p (vs 3.50p), year‑end cash £5.3m (plus a July top‑up raise), 88 granted patents, pilot‑line capacity ~1.5 MWh/yr (c.20,000 10Ah cells/yr), 16 Stereax customers with 19 orders, commenced M300 deliveries, shipped 10A Goliath prototypes and are converting those into a 10A MVP with early non‑automotive commercial opportunities (defence, e‑bikes/Brompton) and expected further grant support leading to option‑to‑license milestones; modeling with Balance indicated a c.20% weight (and range) benefit and a 1/3 reduction in charge time (18→12 minutes) for Goliath in a Hyundai Ioniq 5.

Ilika plc Risk Analysis

Ilika plc disclosed 6 risk factors in its most recent earnings report. Ilika plc reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Ilika plc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

ILIKF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:VLXGB:VLX67NeutralGBP 977.77M21.5115.29%0.85%8.85%29.67%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
GB:GELNGB:GELN49NeutralGBP 44.05M-6.31-40.88%―-94.63%24.26%
GB:XPPGB:XPP49NeutralGBP 455.47M-54.10-4.89%―-1.21%46.27%
GB:CWRGB:CWR41NeutralGBP 564.98M-16.04-17.63%―-22.86%-25.81%

* Industrials Sector Average

Performance Comparison

-50%0%50%100%ILIKFGB:CWRGB:VLXGB:XPPGB:GELNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
ILIKF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ILIKFIlika plc0.26-0.33-56.34%
GB:CWRCeres Power Holdings275.20-95.80-25.82%
GB:VLXVolex plc567.00143.6533.93%
GB:XPPXP Power1700.00755.0079.89%
GB:GELNGelion PLC19.50-1.00-4.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.